Obesity and pregnancy: mechanisms of short term and long term adverse consequences for mother and child
Effects of glucagon-like peptide-1 receptor agonists on weight loss: systematic review and meta-analyses of randomised controlled trials
Not necessarily, but for some families, weaning or reducing feeds may become part of the plan after a healthcare discussion
There are several higher-risk situations, including dose escalation, constipation, nausea, vomiting, stomach pain, breathing trouble, higher-than-typical doses, and other conditions that slow stomach emptying
Lifestyle changes remain the foundation of treatment
GLP-1/GCG Dual Agonism GCG is a pancreatic hormone secreted from -cells